NuVasive, Inc. (NUVA) Stock Overview
Explore NuVasive, Inc.’s financial performance, market position, analyst ratings, and future outlook.
NuVasive, Inc. (NUVA)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
50.96
EPS (TTM)
$0.53
ROE
0.05%
NUVA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of NuVasive, Inc. (NASDAQ: NUVA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, NuVasive, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NUVA on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind NuVasive, Inc.'s NASDAQ-traded stock include a P/E ratio of 50.96 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NUVA on the NASDAQ.